Nature Bank is a unique drug discovery platform based on natural product extracts, fractions and compounds that have been derived from Australian plants and marine invertebrates.
These samples have been processed into two libraries (a 10,000 natural product extract library and a 50,000 natural product fraction library), which are both ready for High Throughput Screening against any disease. In addition there are more than 45,000 archived biota samples (January 2017).
Nature Bank can accelerate drug discovery and is accessible to researchers around the world. By 2016, Nature Bank libraries were shared with more than 30 universities, research institutes and pharmaceutical and biotechnology companies.
How it works
Nature Bank is housed at GRIDD under the custodianship of the Director, Professor Jennifer Martin. Working with global disease experts ensures the best team for the job. Nature Bank is already being used to search for new drugs for malaria, African sleeping sickness, cancer, Parkinson’s disease, schizophrenia, stroke, thrombosis, tuberculosis, HIV, Alzheimer’s and many other diseases.
Nature Bank services available
GRIDD offers the following services:
- Supply of the Nature Bank extract or fraction library for screening on your assay systems, with follow-up isolation chemistry at GRIDD
- Screening of the Nature Bank extract or fraction library against your drug target, using our advanced High Throughput Screening systems